Barley consumption under a high-fat diet suppresses lipogenic genes through altered intestinal bile acid composition

J Nutr Biochem. 2024 Mar:125:109547. doi: 10.1016/j.jnutbio.2023.109547. Epub 2023 Dec 9.

Abstract

We evaluated whether barley flour consumption in a high-fat environment affects lipid metabolism through signals mediated by bile acids. Four-week-old mice were fed a high-fat diet supplemented with cellulose (HC) or β-glucan-rich barley flour (HB) for 12 weeks. Bile acid composition in the intestinal tract and feces was measured by GC/MS. Gene expression levels involved in bile acid metabolism in the liver and intestinal tract were determined by RT-PCR. Similar parameters were measured in mice treated with antibiotics (antibiotics-cellulose [AC] and antibiotics-barley [AB]) to reduce the activity of intestinal bacteria. The Results showed that the HB group had lower liver blood cholesterol and triglyceride levels than the HC group. The HB group showed a significant decrease in primary bile acids in the gastrointestinal tract compared to the HC group. On the other hand, the concentration of secondary bile acids relatively increased in the cecum and feces. In the liver, Fxr activation suppressed gene expression levels in synthesizing bile acids and lipids. Furthermore, in the gastrointestinal tract, Tgr5 was activated by increased secondary bile acids. Correspondingly, AMP levels were increased in the HB group compared to the HC group, AMPK was phosphorylated in the liver, and gene expression involved in lipid synthesis was downregulated. A comparison of the AC and AB groups treated with antibiotics did not confirm these effects of barley intake. In summary, our results suggest that the prevention of lipid accumulation by barley consumption involves signaling through changes in bile acid composition in the intestinal tract.

Keywords: Barley; Bile acids; Farnesoid X receptor; Lipid metabolism; Takeda-G-protein-receptor-5; β-glucan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Bile Acids and Salts / metabolism
  • Cellulose / metabolism
  • Cellulose / pharmacology
  • Diet, High-Fat* / adverse effects
  • Hordeum* / metabolism
  • Lipid Metabolism
  • Lipids / pharmacology
  • Liver / metabolism
  • Mice
  • Mice, Inbred C57BL

Substances

  • Bile Acids and Salts
  • Lipids
  • Cellulose
  • Anti-Bacterial Agents